跳至主要内容
临床试验/IRCT2016071325160N4
IRCT2016071325160N4已完成2 期

Comparing the effect of different doses of Buprenorphine (32 mg- 64 mg- 96 mg) on the reduction of opioid withdrawal symptoms and reduction of their depression and suicidal thoughts

Shiraz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 60 years(—)
性别
Male

入选标准

  • Inclusion Criteria:age between 16 to 60 y/o; informed consent;Opioid dependence
  • Exclusion criteria:Patients unwilling to participate at beginning or during the study; use of other substances except Opioid as of the main substance.

排除标准

  • 未提供

研究者

相似试验